Physician

Marcus K. Weldon, MD

According to 2025 Medicare claims, Marcus Weldon, MD (NPI: 1942689286) practices hematology/oncology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 31088-9998. Weldon is affiliated with the TC2, LLC (ACO ID: A3365) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Weldon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,485 traditional Medicare patients, billed 279,594 HCPCS/CPT codes, and received $5,222,431 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,435 prescription claims across 392 beneficiaries totaling $2,343,826 in drug costs, led by Xtandi (Enzalutamide). DME data shows 45 claims. Open Payments data shows 124 records totaling $3,124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $4,939 to $2,343,826. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,121 to $11,490.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2021 Medicare payment: $1,763,511 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,636,875 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,197,383 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,222,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202175596,271$1,763,511
20221,297229,143$3,636,875
20231,393278,846$4,197,383
20241,485279,594$5,222,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $4,939 (USD; Tot_Drug_Cst)2016 Drug cost: $31,826 (USD; Tot_Drug_Cst)2017 Drug cost: $9,444 (USD; Tot_Drug_Cst)2018 Drug cost: $20,144 (USD; Tot_Drug_Cst)2019 Drug cost: $39,640 (USD; Tot_Drug_Cst)2020 Drug cost: $29,769 (USD; Tot_Drug_Cst)2021 Drug cost: $199,923 (USD; Tot_Drug_Cst)2022 Drug cost: $2,001,894 (USD; Tot_Drug_Cst)2023 Drug cost: $1,975,310 (USD; Tot_Drug_Cst)2024 Drug cost: $2,343,826 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R42$4,939
201638347$31,826
201737199$9,444
201839181$20,144
201953210$39,640
202027116$29,769
2021104243$199,923
2022281991$2,001,894
20233161,328$1,975,310
20243921,435$2,343,826

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.3K$4.5K2016 Medicare payment: $1,085 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,706 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,210 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $269 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,731 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,512 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,598 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R22$1,085
2017N/R46$1,706
2018N/R28$1,210
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R35$269
202214113$1,731
20231141$4,512
2024N/R45$1,598

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8701,432$93
82728Ferritin (blood protein) level450628$13
80053Blood test, comprehensive group of blood chemicals9361,903$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count1,0992,471$8
83540Iron level404531$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide391,170$540,120
TagrissoOsimertinib Mesylate22660$375,887
ImbruvicaIbrutinib28806$361,018
EliquisApixaban571,860$34,120
Abiraterone AcetateAbiraterone Acetate16480$26,250

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R13$1,082
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R19$288
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R13$228

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.124$3,124Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marcus K. Weldon, MD?

Tedicare shows public-source Medicare data for Marcus K. Weldon, MD (NPI 1942689286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marcus K. Weldon, MD have ACO affiliation data?

Marcus K. Weldon, MD is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Marcus K. Weldon, MD?

Marcus K. Weldon, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Marcus K. Weldon, MD have Open Payments data?

Marcus K. Weldon, MD has 124 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.